Evidence map›Paper›PMID 30994090›Full record

Trial reportThe American journal of tropical medicine and hygiene2019

Safety and Differential Antibody and T-Cell Responses to the

Said A Jongo, L W Preston Church, Ali T Mtoro, Sumana Chakravarty, Adam J Ruben, Phillip A Swanson, Kamaka R Kassim, Maximillian Mpina, Anneth-Mwasi Tumbo, Florence A Milando and 23 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 6 institutions in 3 countries.

Said A JongoIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
L W Preston ChurchSanaria, Inc., Rockville, Maryland.
Ali T MtoroIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Sumana ChakravartySanaria, Inc., Rockville, Maryland.
Adam J RubenSanaria, Inc., Rockville, Maryland.
Phillip A SwansonVaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Kamaka R KassimIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Maximillian MpinaUniversity of Basel, Basel, Switzerland.
Anneth-Mwasi TumboUniversity of Basel, Basel, Switzerland.
Florence A MilandoIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Munira QassimIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Omar A JumaIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Bakari M BakariIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Beatus SimonIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Eric R JamesSanaria, Inc., Rockville, Maryland.
Yonas AbebeSanaria, Inc., Rockville, Maryland.
Natasha KcSanaria, Inc., Rockville, Maryland.
Elizabeth SaverinoSanaria, Inc., Rockville, Maryland.
Linda GondweUniversity of Basel, Basel, Switzerland.
Fabian StuderUniversity of Basel, Basel, Switzerland.
Martina FinkUniversity of Basel, Basel, Switzerland.
Glenda CosiUniversity of Basel, Basel, Switzerland.
Jill El-KhorazatyThe Emmes Corporation, Rockville, Maryland.
David StyersThe Emmes Corporation, Rockville, Maryland.
Robert A SederVaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Tobias SchindlerUniversity of Basel, Basel, Switzerland.
Peter F BillingsleySanaria, Inc., Rockville, Maryland.
Claudia DaubenbergerUniversity of Basel, Basel, Switzerland.
B Kim Lee SimProtein Potential LLC, Rockville, Maryland.
Marcel TannerUniversity of Basel, Basel, Switzerland.
Thomas L RichieSanaria, Inc., Rockville, Maryland.
Salim AbdullaIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
Stephen L HoffmanSanaria, Inc., Rockville, Maryland.
Sanaria · USIfakara Health Institute · TZUniversity of Basel · CHSwiss Tropical and Public Health Institute · CHEmmes (United States) · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016, there were more cases and deaths caused by malaria globally than in 2015. An effective vaccine would be an ideal additional tool for reducing malaria's impact. Sanaria

Indexed as

AdolescentAdultAntibodies, ProtozoanAntibody FormationChildChild, PreschoolDouble-Blind MethodFemaleHumansInfantMalaria, FalciparumMalaria VaccinesMaleMiddle AgedPlasmodium falciparumTanzaniaAntibodies, ProtozoanMalaria VaccinesVaccines, Attenuated

Identifiers

PMID30994090
PMCPMC6553883
OpenAlexW2936057785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.